These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 22783792)

  • 21. What does the generalist need to know about HIV infection?
    Gallant JE
    Adv Chronic Kidney Dis; 2010 Jan; 17(1):5-18. PubMed ID: 20005484
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Unexpected effects of inhaled fluticasone in an HIV patient with asthma.
    Nocent C; Raherison C; Dupon M; Taytard A
    J Asthma; 2004; 41(8):793-5. PubMed ID: 15641628
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of Therapeutic Drug Monitoring of Antiretroviral Drugs in Routine Clinical Management of People Living With HIV: A Narrative Review.
    Cattaneo D; Baldelli S; Cozzi V; Clementi E; Marriott DJE; Gervasoni C;
    Ther Drug Monit; 2020 Feb; 42(1):64-74. PubMed ID: 31393332
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Med-psych drug-drug interactions update. Antiretrovirals, part III: antiretrovirals and drugs of abuse.
    Wynn GH; Cozza KL; Zapor MJ; Wortmann GW; Armstrong SC
    Psychosomatics; 2005; 46(1):79-87. PubMed ID: 15765827
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug interactions with antiretrovirals.
    Catanzaro LM; Slish JC; DiCenzo R; Morse GD
    Curr HIV/AIDS Rep; 2004 Jun; 1(2):89-96. PubMed ID: 16091228
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impaired lipoprotein processing in HIV patients on antiretroviral therapy: aberrant high-density lipoprotein lipids, stability, and function.
    Gillard BK; Raya JL; Ruiz-Esponda R; Iyer D; Coraza I; Balasubramanyam A; Pownall HJ
    Arterioscler Thromb Vasc Biol; 2013 Jul; 33(7):1714-21. PubMed ID: 23640486
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LIPID abnormalities in patients infected with human immunodeficiency virus.
    Mikhail NE
    Endocr Pract; 2008; 14(4):492-500. PubMed ID: 18558606
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug interactions between proton pump inhibitors and antiretroviral drugs.
    McCabe SM; Smith PF; Ma Q; Morse GD
    Expert Opin Drug Metab Toxicol; 2007 Apr; 3(2):197-207. PubMed ID: 17428151
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of fluconazole in a case of rapid onset ritonavir and inhaled fluticasone-associated secondary adrenal insufficiency.
    St Clair K; Maguire JD
    Int J STD AIDS; 2012 May; 23(5):371-2. PubMed ID: 22648897
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Avascular necrosis in a HIV patient receiving ritonavir and inhaled fluticasone.
    Pollett S; Graves B; Richards B; MacLeod C
    Int J STD AIDS; 2014 May; 25(6):458-60. PubMed ID: 24287027
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stopping antiretroviral therapy: role for therapeutic drug monitoring.
    Tommasi C; Nicastri E; Corpolongo A; Ivanovic J; Notari S; Ascenzi P; Andreoni M; Narciso P
    AIDS; 2008 Jan; 22(2):315-6. PubMed ID: 18097237
    [No Abstract]   [Full Text] [Related]  

  • 32. [Determination of serum levels of antiretroviral drugs].
    Kurowski M
    MMW Fortschr Med; 2004 Apr; 146 Spec No 1():62-4. PubMed ID: 15373053
    [No Abstract]   [Full Text] [Related]  

  • 33. Systemic bioavailability of fluticasone propionate administered as nasal drops and aqueous nasal spray formulations.
    Daley-Yates PT; Baker RC
    Br J Clin Pharmacol; 2001 Jan; 51(1):103-5. PubMed ID: 11167672
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rhabdomyolysis after cerivastatin-gemfibrozil therapy in an HIV-infected patient with protease inhibitor-related hyperlipidemia.
    Mastroianni CM; d'Ettorre G; Forcina G; Lichtner M; Corpolongo A; Coletta S; Vullo V
    AIDS; 2001 Apr; 15(6):820-1. PubMed ID: 11371708
    [No Abstract]   [Full Text] [Related]  

  • 35. Ritonavir-fluticasone interaction causing Cushing syndrome in HIV-infected children and adolescents.
    Arrington-Sanders R; Hutton N; Siberry GK
    Pediatr Infect Dis J; 2006 Nov; 25(11):1044-8. PubMed ID: 17072128
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiovascular risk and body-fat abnormalities in HIV-infected adults.
    Grinspoon S; Carr A
    N Engl J Med; 2005 Jan; 352(1):48-62. PubMed ID: 15635112
    [No Abstract]   [Full Text] [Related]  

  • 37. Antiretroviral drug treatment of CNS HIV-1 infection.
    Yilmaz A; Price RW; Gisslén M
    J Antimicrob Chemother; 2012 Feb; 67(2):299-311. PubMed ID: 22160207
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Response to 'Communicating information about drug interactions'.
    Back DJ; Gibbons SE
    Br J Clin Pharmacol; 2008 Apr; 65(4):617-8. PubMed ID: 17995974
    [No Abstract]   [Full Text] [Related]  

  • 39. The human pharmacology of fluticasone propionate.
    Harding SM
    Respir Med; 1990 Nov; 84 Suppl A():25-9. PubMed ID: 2287792
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dyslipidemia in HIV patients.
    Tungsiripat M; Aberg JA
    Cleve Clin J Med; 2005 Dec; 72(12):1113-20. PubMed ID: 16392725
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.